IP Library › Assignment 063349/0100
Patent Assignment
Reel/Frame 063349/0100

Change of Name

Recorded: 2023-04-14 Pages: 5
Assignor
SUNESIS PHARMACEUTICALS, INC.
Executed: 2021-02-24
Assignee
VIRACTA THERAPEUTICS, INC.
2533 S. COAST HWY 101, SUITE 210, CARDIFF, CALIFORNIA, 92007
Covered Properties (4)
Compounds Useful as Raf Kinase Inhibitors
Patent: 8,293,752 →
Application: 12/164,762 →
Publication: US 2009/0036419
Compounds Useful as Raf Kinase Inhibitors
Patent: 8,802,657 →
Application: 13/657,506 →
Publication: US 2013/0065858
Substituted 1,3-Thiazoles as Synthetic Intermediates for Preparation of Raf Kinase Inhibitors
Patent: 9,556,177 →
Application: 14/444,007 →
Publication: US 2015/0080568
Substituted Pyrimidines for Inhibiting Raf Kinase Activity
Patent: 9,920,048 →
Application: 15/380,515 →
Publication: US 2017/0158686
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 16, 2008
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 021707/0639 →
Assignment of Assignor's Interest Oct 16, 2008
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 021688/0887 →
Confirmation of Assignment-Joint Ownership Between Biogen Idec Ma Inc. and Sunesis Pharmaceuticals, Inc. Jul 17, 2009
From: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
To: SUNESIS PHARMACEUTICALS, INC.; BIOGEN IDEC MA INC.
Reel/Frame 022974/0461 →
Confirmation of Assignment-Joint Ownership Between Biogen Idec Ma Inc. and Sunesis Pharmaceutcials, Inc. Jul 17, 2009
From: SUNESIS PHARMACEUTICALS, INC.; BIOGEN IDEC MA INC.
To: SUNESIS PHARMACEUTICALS, INC.; BIOGEN IDEC MA INC.
Reel/Frame 022974/0444 →
Assignment of Assignor's Interest Dec 23, 2011
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 027441/0954 →
Assignment of Assignor's Interest Jul 24, 2015
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 036175/0621 →
Assignment of Assignor's Interest Jul 24, 2015
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 036175/0639 →
Assignment of Assignor's Interest Jul 24, 2015
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 036175/0586 →
Assignment of Assignor's Interest Jan 23, 2018
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 044695/0001 →
Assignment of Assignor's Interest Jan 23, 2018
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 044694/0982 →
Assignment of Assignor's Interest Jan 23, 2018
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 044695/0020 →
Assignment of Assignor's Interest Apr 1, 2020
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 052288/0694 →
Assignment of Assignor's Interest Jan 14, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 054921/0546 →
Assignment of Assignor's Interest Jan 14, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 054921/0863 →
Assignment of Assignor's Interest Jan 14, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 054921/0669 →
Assignment of Assignor's Interest Mar 8, 2021
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 055524/0371 →
Assignment of Assignor's Interest Mar 8, 2021
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 055524/0525 →
Assignment of Assignor's Interest Mar 8, 2021
From: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
To: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 055524/0457 →
Assignment of Assignor's Interest Mar 8, 2021
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 055524/0173 →
Merger May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Assignment of Assignor's Interest Dec 3, 2024
From: VIRACTA THERAPEUTICS, INC.
To: XOMA (US) LLC
Reel/Frame 069474/0049 →
Security Interest Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →